Ben Harshbarger has served as Novelion’s Interim Chief Executive Officer since November 2018 and as its General Counsel since November 2016. Prior to that, he served as Aegerion’s Vice President, EMEA Legal Counsel from January 2014 to September 2015 and as Aegerion’s Vice President, Deputy General Counsel from April 2012 to January 2014. Before joining Aegerion, he served as Senior Director, Corporate Counsel at Cubist Pharmaceuticals, Inc. from March 2008 to March 2012, and Senior Director, Deputy General Counsel at ViaCell, Inc. from March 2006 to March 2008. He served in several legal positions of increasing responsibility at Biogen Idec Corporation from November 2001 to March 2006 and served as an associate at the law firm of Mintz Levin from 1996 to 2001. Mr. Harshbarger has a J.D. from Boston College Law School and a B.A. from the University of Richmond.
Michael Price serves Novelion as Executive Vice President and Chief Financial Officer and, since his appointment in October 2019, as a member of the Board of Directors. Prior to joining Novelion in December of 2017, he served as Vice President and Chief Financial Officer for Noven Pharmaceuticals, Inc. (“Noven”), a NASDAQ-listed company until its acquisition by Hisamitsu Pharmaceutical Company. Noven is a specialty pharmaceutical company engaged in the research, development, manufacturing, marketing and sale of prescription pharmaceutical products. In his role at Noven, Mr. Price was directly involved with the development and execution of strategy that scaled the Company's commercial organization and significantly increased revenues. Prior to Noven, he was Vice President, Chief Financial Officer, Treasurer, Secretary and a member of the Board of Directors for Bentley Pharmaceuticals, a New York Stock Exchange-listed company until its acquisition by Teva Pharmaceutical Industries. Mr. Price is a certified public accountant. He holds a bachelor of science degree in business administration (accounting) from Auburn University and a master of business administration degree from Florida State University.
Linda Buono has served as Novelion’s Senior Vice President, Human Resources since November 2016. Prior to Novelion, she joined Aegerion in July 2016 as Senior Vice President, Human Resources. Prior to Aegerion, she spent more than 25 years at Immunogen where she held a variety of leadership positions in Human Resources. Ms. Buono is effective in managing all the critical tasks and responsibilities of the Human Resources function and has facilitated recruitment of top talent across the organization.